Literature DB >> 30825500

CD36 signaling in vascular redox stress.

Moua Yang1, Roy L Silverstein2.   

Abstract

Scavenger receptor CD36 is a multifunctional membrane protein that promotes thrombosis in conditions of oxidative stress such as metabolic disorders including dyslipidemia, diabetes mellitus, and chronic inflammation. In these conditions, specific reactive oxidant species are generated that are context and cell dependent. In the vasculature, CD36 signaling in smooth muscle cells and endothelial cells promotes generation of reactive oxygen species, genetic downregulation of antioxidant genes, and impaired smooth muscle and endothelial function. In hematopoietic cells, CD36 signaling enhances platelet dysfunction thus decreasing the threshold for platelet activation and accelerating arterial thrombosis, whereas in macrophages, CD36 promotes lipid-laden foam cell formation and atherosclerosis. These clinically significant processes are mediated through complex redox regulated signaling mechanisms that include Src-family kinases, MAP kinases and other downstream effectors. We provide an overview of CD36 signaling in vascular redox stress highlighting the role in oxidant generation in vascular and hematopoietic cells, but with special emphasis on platelets and dyslipidemia.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30825500      PMCID: PMC6488418          DOI: 10.1016/j.freeradbiomed.2019.02.021

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   8.101


  104 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 3.  Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration.

Authors:  Matthias Krause; Erik W Dent; James E Bear; Joseph J Loureiro; Frank B Gertler
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

4.  Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma.

Authors:  J Feng; J Han; S F Pearce; R L Silverstein; A M Gotto; D P Hajjar; A C Nicholson
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

5.  Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.

Authors:  C T Coburn; F F Knapp; M Febbraio; A L Beets; R L Silverstein; N A Abumrad
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

Review 6.  Pathophysiology of human genetic CD36 deficiency.

Authors:  Ken-ichi Hirano; Takahiro Kuwasako; Yumiko Nakagawa-Toyama; Mohamed Janabi; Shizuya Yamashita; Yuji Matsuzawa
Journal:  Trends Cardiovasc Med       Date:  2003-05       Impact factor: 6.677

7.  Ectoprotein kinase-mediated phosphorylation of FAT/CD36 regulates palmitate uptake by human platelets.

Authors:  F Guthmann; P Maehl; J Preiss; I Kolleck; B Rüstow
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

8.  Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Bogdan Gugiu; Paul L Fox; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

9.  CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum.

Authors:  Todd G Smith; Lena Serghides; Samir N Patel; Maria Febbraio; Roy L Silverstein; Kevin C Kain
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide.

Authors:  Hongtao Zhao; Shasi Kalivendi; Hao Zhang; Joy Joseph; Kasem Nithipatikom; Jeannette Vásquez-Vivar; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2003-06-01       Impact factor: 7.376

View more
  10 in total

1.  Novel Regulators and Targets of Redox Signaling in Pulmonary Vasculature.

Authors:  Zdravka Daneva; Victor E Laubach; Swapnil K Sonkusare
Journal:  Curr Opin Physiol       Date:  2019-05-09

Review 2.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

3.  PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP".

Authors:  Roy L Silverstein
Journal:  Circulation       Date:  2020-12-30       Impact factor: 29.690

Review 4.  CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.

Authors:  Moua Yang; Roy L Silverstein
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.218

5.  Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia.

Authors:  Moua Yang; Wei Li; Calvin Harberg; Wenjing Chen; Hong Yue; Renan B Ferreira; Sarah L Wynia-Smith; Kate S Carroll; Jacek Zielonka; Robert Flaumenhaft; Roy L Silverstein; Brian C Smith
Journal:  Blood Adv       Date:  2020-09-22

Review 6.  Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes.

Authors:  Amélie I S Sobczak; Claudia A Blindauer; Alan J Stewart
Journal:  Nutrients       Date:  2019-08-28       Impact factor: 5.717

7.  Inducible co-stimulator inhibits lipid phagocytosis of human aortic smooth muscle cells by down-regulating CD36 expression.

Authors:  Meng Liang; Xuemin Guo; Heming Wu; Zhixiong Zhong
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 2.895

Review 8.  Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease.

Authors:  Joseph E Rupert; Mikhail G Kolonin
Journal:  Immunometabolism (Cobham)       Date:  2022-08-15

Review 9.  Oxidative Cysteine Modification of Thiol Isomerases in Thrombotic Disease: A Hypothesis.

Authors:  Moua Yang; Robert Flaumenhaft
Journal:  Antioxid Redox Signal       Date:  2021-09-13       Impact factor: 8.401

10.  Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake.

Authors:  Frederik Denorme; Irina Portier; Yasuhiro Kosaka; Robert A Campbell
Journal:  J Thromb Haemost       Date:  2020-11-27       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.